Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?
Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...
Are Hedge Funds Betting Big on Novo Nordisk (NVO)’s Diabetes and Chronic Disease Care?
We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...
devdiscourse1d
FDA's Game-Changing Approvals and Global Health Alerts
The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
GlobalData on MSN1d
“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
Catalent gains on reports it's likely to be granted EU approval for Novo Holdings deal (update)
The European Commission is expected to give unconditional approval for the $16.5 billion purchase of Catalent (NYSE: CTLT) as ...
Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...
Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
Ypsomed will make injection pens for Novo Nordisk's CagriSema, says source
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
Becker's Hospital Review2d
Drugmakers, pharmacists battle over who gets obesity drugs: 5 things to know
The battle over who should provide obesity and diabetes drugs like Ozempic and Wegovy has reached a critical point, as manufacturers and compounding pharmacies clash over the demand of these ...
Health.com2d
Are You Eligible for Ozempic? New Study Suggests Over Half of U.S. Adults Qualify
New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...
BioPharma Dive3d
Versant startup sets out to make a new type of obesity drug
The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a ...